Satellos Bioscience Inc.
MSCL.TO
TSX
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 180.02% | -14.33% | -17.38% | -18.28% | -8.39% |
Total Receivables | 207.71% | -80.73% | 11.00% | 49.69% | 68.25% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 310.59% | 15.03% | 141.48% | 37.64% | 104.94% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -68.18% | -26.67% | -31.82% |
Total Current Assets | 183.37% | -16.11% | -15.68% | -17.09% | -7.60% |
|
|||||
Total Current Assets | 183.37% | -16.11% | -15.68% | -17.09% | -7.60% |
Net Property, Plant & Equipment | -72.22% | -13.70% | 4.29% | -2.78% | -2.70% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -1.06% | -2.48% | 2.44% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 183.19% | -26.11% | -14.15% | -15.78% | -6.78% |
|
|||||
Total Accounts Payable | 103.27% | -12.81% | -9.84% | 63.92% | 5.79% |
Total Accrued Expenses | -8.77% | -6.31% | 20.05% | -24.29% | 102.04% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 33.63% | -8.88% | 6.13% | 1.03% | 60.21% |
|
|||||
Total Current Liabilities | 33.63% | -8.88% | 6.13% | 1.03% | 60.21% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 33.63% | -8.88% | 6.13% | 1.03% | 60.21% |
|
|||||
Common Stock & APIC | 55.70% | 2.17% | -0.03% | -4.87% | 9.44% |
Retained Earnings | -2.14% | -16.47% | -9.91% | -11.71% | -18.77% |
Treasury Stock & Other | 28.05% | 0.72% | -1.14% | 11.09% | -15.08% |
Total Common Equity | 209.50% | -28.49% | -16.36% | -17.27% | -10.13% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 209.50% | -28.49% | -16.36% | -17.27% | -10.13% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 209.50% | -28.49% | -16.36% | -17.27% | -10.13% |
|